Additional Information
DescriptionWegovy® (semaglutide) injection is an FDA-approved prescription medication. It has undergone rigorous FDA evaluation for safety, efficacy, and quality. This product is supplied with a full FDA-approved prescribing label.
Wegovy® contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, and is indicated for chronic weight management. The 0.5 mg/.5 mL pen is intended for initial dose escalation according to the approved prescribing schedule.
Dispensed only pursuant to a valid prescription. For subcutaneous injection only. Dosing must be determined and supervised by a qualified healthcare professional in accordance with the official prescribing information.
Important Safety Notice: This is an FDA-approved drug with a established safety and efficacy profile. Patients should be counseled on the potential side effects, including serious ones such as thyroid C-cell tumors, pancreatitis, and gallbladder disease, as described in the Boxed Warning and full prescribing information.
You've just added this product to thecart:
